IQVIA Announces Pricing of Senior Notes
Stocks in this Quantisnow insightHealth Care
Historical context for IQV
Across the 28 sessions after earlier IQV headlines, the stock closed higher 13 times and lower 15 times, with a median move of 2.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | IQV | SPY |
|---|---|---|---|
| Sep 9, 2026 | IQVIA Announces Offering of Senior Notes | -0.9% | -0.5% |
| Sep 4, 2026 | IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster | -1.4% | -0.4% |
| Aug 28, 2026 | IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare | -0.2% | -0.2% |
| Aug 21, 2026 | IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year | +1.5% | +0.4% |
| Aug 18, 2026 | IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group | -0.5% | -0.7% |
| Aug 5, 2026 | IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery | +3.4% | -0.2% |
Quantisnow market dataNYSE
IQV
IQVIA Holdings Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Listed since
- 2013
Get push alerts for IQV
Full IQV profile on Quantisnow Follow IQV and get a push notification the moment its next story breaks.